- GAAP net sales of $1.0 billion, an increase of 10% year-over-year; non-GAAP pro forma organic net sales increased 5% year-over-year
- Net loss of $906 million, including a non-cash goodwill impairment charge of $939 million; non-GAAP adjusted net income of $19 million, a decline of 10% year-over-year on a pro forma basis
- Non-GAAP adjusted EBITDA of $49 million, a decline of 4% year-over-year on a pro forma basis
- Non-GAAP 2019 pro forma adjusted EBITDA expected to be in a range of $190 million to $196 million
PORTLAND, Maine. November 12, 2019 — Covetrus (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the third quarter of 2019, which ended September 30, 2019.
“Our team is unified in our belief in the Covetrus business model and the power of our integrated platform to drive measurable value for our customers, shareholders, employees and partners,” said Benjamin Wolin, Covetrus acting president and CEO. “We have the assets, we have the relationships, we have the technology tools our customers need, and we are in a growing market. With a relentless focus on execution and the core drivers of our business, we will continue to innovate and grow.”
Read the full press release here: https://ir.covetrus.com/news-releases/news-release-details/covetrus-announces-financial-results-third-quarter-2019